Back to search

Article

Genomic ascertainment to quantify prevalence and cancer risk in adults with pathogenic and likely pathogenic germline variants in RASopathy genes

2024-10-11

Abstract excerpt

<h4>Purpose</h4> Genomic ascertainment of electronic health record-linked exome data in two large biobanks was used to quantify germline pathogenic/likely pathogenic (P/LP) variant prevalence, cancer prevalence, and survival in adults with non- NF1 RAS/mitogen-activated protein kinase genes (RASopathies). <h4>Patients and Methods</h4> Germline RASopathy variants were examined from adult participants in UK Biobank...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ea7a5fbf-d494-5b82-b7b6-170a05b68e34
DOI
10.1101/2024.10.09.24314324
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Genomic ascertainment to quantify prevalence and cancer risk in adults with pathogenic and likely pathogenic germline variants in RASopathy genesDOI 10.1101/2024.10.09.24314324
Select a neighboring publication to make it the new centre.